Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 18Colonic Neoplasms 18Stomach Neoplasms 13Ovarian Neoplasms 10Neoplasms 5Gastrointestinal Stromal Tumors 5Carcinoma, Hepatocellular 5Peritoneal Neoplasms 4Endometrial Neoplasms 4Carcinoma, Renal Cell 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Liver Neoplasms 3Kidney Neoplasms 3Prostatic Neoplasms 2Neoplastic Cells, Circulating 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Venous Thrombosis 1Uterine Neoplasms 1Urinary Incontinence 1Surgical Wound Infection 1Sexual Dysfunction, Physiological 1Robotic 1Polycystic Ovary Syndrome 1Pancreatic Neuroendocrine Tumors 1

Interventions

Gemcitabine 114Cisplatin 78Oxaliplatin 46pembrolizumab 36Fluorouracil 33Capecitabine 32lenvatinib 27durvalumab 27Leucovorin 27Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10S 1 (combination) 9Folfox protocol 9Bevacizumab 9Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Laparoscopy × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡